C-Prio Ltd

C-Prio develop and provide histopathology AI models for drug discovery and personalised medicine with exceptionally high granularity, accuracy, training efficiency. Specially good to stratify patient population to boost safety and efficacy for new therapies, based on histopathology digital images. 

We have won a few prize for our innovation and products. 


We are currently collaborating with three UK NHS hospitals to validate rAI-colon for streamlining histopathology workflow on colorectal biopsies.